CHA2DS2-VASc Risk Scheme Not Ready for Clinical Use

被引:7
作者
Singer, Daniel E. [1 ]
Fang, Margaret C. [2 ]
Go, Alan S. [2 ,3 ,4 ]
机构
[1] Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Gen Med, Boston, MA 02114 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Kaiser Permanente No Calif, Div Res, Oakland, CA USA
关键词
EURO HEART SURVEY; ATRIAL-FIBRILLATION;
D O I
10.1378/chest.10-0875
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1020 / 1020
页数:1
相关论文
共 4 条
[1]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[2]  
2-4
[3]   Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation [J].
Lip, Gregory Y. H. ;
Nieuwlaat, Robby ;
Pisters, Ron ;
Lane, Deirdre A. ;
Crijns, Harry J. G. M. .
CHEST, 2010, 137 (02) :263-272
[4]   Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year:: follow-up of the Euro Heart Survey on Atrial Fibrillation [J].
Nieuwlaat, Robby ;
Prins, Martin H. ;
Le Heuzey, Jean-Yves ;
Vardas, Panos E. ;
Aliot, Etienne ;
Santini, Massimo ;
Cobbe, Stuart M. ;
Widdershoven, Jos W. M. G. ;
Baur, Leo H. ;
Levy, Samuel ;
Crijns, Harry J. G. M. .
EUROPEAN HEART JOURNAL, 2008, 29 (09) :1181-1189